Of the 287 patients who initiated endocrine therapy, 191 (66.6%) fully completed this treatment.
In conclusion, this study confirms two recent reports (Neugut et al, 2006; Dobie et al, 2006) that stage III colon cancer patients who fail to complete 5FU adjuvant chemotherapy show worse survival than patients who completed this treatment.
On the basis of these results and for this study, patients who received 4 6 cycles were classified as having completed chemotherapy, whereas those treated with 1 3 cycles were deemed not to have completed this treatment.
As well as the encouraging results with respect to overall survival, it is also particularly encouraging that, several weeks after completing this treatment, patients frequently feel very well and most notably their dysphagia has usually resolved.
Although the primary goal of this study was to determine the proportion of patients that can complete this outpatient treatment, and their treatment response, intent-to-treat data are reported in Table 1.
Although the primary goal of this study was to determine the proportion of patients with marked anorexia nervosa who can complete this outpatient treatment, and their treatment response, intent-to-treat data are reported in Table 2.
Sixty-four percent of the patients were able to complete this outpatient treatment and in these patients there was a substantial increase in weight (7.47 kg, SD 4.93) and BMI (2.77, SD 1.81).
First, among adults with marked anorexia nervosa, what proportion is able to complete this outpatient treatment?
The first was that two-thirds of the patients in both samples were able to complete this lengthy treatment.
Dr. Donna Weber, a specialist at the University of Texas M. D. Anderson Cancer Center, said that about 4 in every 10 people experience complete remission with this treatment, which means no sign of the cancerous cells appear on later tests.
